Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the efficacy of YKP3089 in reducing seizure frequency when compared
to baseline in subjects with partial onset seizures not fully controlled despite their
treatment with 1 to 3 concomitant anti-epileptic drugs.
Also to evaluate the safety and tolerability of YKP3089.